CHRNA2 Target & Gene Products-cDNA ORF clones/siRNA/antibody/protein

Explore CHRNA2 gene products and cross-species research data at TarMart platform. Discover comprehensive biological information, expression tools, and therapeutic insights for Homo sapiens (human), Cynomolgus monkeys, rodents (mouse/rat), canines, felines, bovines, and equines. Your premier destination for multi-species gene research solutions
Target sublocation: Transmembrane Protein.
Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels formed by a pentameric arrangement of alpha and beta subunits to create distinct muscle and neuronal receptors. Neuronal receptors are found throughout the peripheral and central nervous system where they are involved in fast synaptic transmission. This gene encodes an alpha subunit that is widely expressed in the brain. The proposed structure for nAChR subunits is a conserved N-terminal extracellular domain followed by three conserved transmembrane domains, a variable cytoplasmic loop, a fourth conserved transmembrane domain, and a short C-terminal extracellular region. Mutations in this gene cause autosomal dominant nocturnal frontal lobe epilepsy type 4. Single nucleotide polymorphisms (SNPs) in this gene have been associated with nicotine dependence. [provided by RefSeq, Nov 2009]

Target ID GM-T55815
Target Name CHRNA2
Gene Group ldentifer
(Target Gene ID in Homo species)
1135
Gene ID 100060380 (Equus caballus), 101092104 (Felis catus), 110902 (Mus musculus), 1135 (Homo sapiens)
170945 (Rattus norvegicus), 486101 (Canis lupus familiaris), 531838 (Bos taurus), 712868 (Macaca mulatta)
Target Alternative Names ACHR,Acra-2,Acra2,CHRNA2,Chrna2,Neuronal acetylcholine receptor subunit alpha-2,nica2
Uniprot Accession Q91X60,Q15822,P12389
Protein Sub-location Transmembrane Protein
Category Therapeutics Target
Disease from KEGG Neuroactive ligand-receptor interaction
Gene Ensembl ENSMUSG00000022041, ENSG00000120903, ENSCAFG00845011451, ENSBTAG00000002252, ENSMMUG00000021514


Pre-made viral vector of CHRNA2 cDNA Clones/ORF Plasmid

Cat No.Product NameNMIDGeneIDSpeciesTypeMarkerFusion TagPromoterDetail
pGMLP001473Human CHRNA2 Lentivirus plasmidNM_0007421135HumanLentivirus plasmidZsGreen3xflag (C-Terminal)CMVDetail
vGMLP001473Human CHRNA2 Lentivirus particleNM_0007421135HumanLentivirus particleZsGreen3xflag (C-Terminal)CMVDetail
pGMLPm004834Mouse Chrna2/Acra-2/Acra2 Lentivirus plasmidNM_144803.2110902MouseLentivirus plasmidZsGreen3xflag (C-Terminal)CMVDetail
vGMLPm004834Mouse Chrna2/Acra-2/Acra2 Lentivirus particleNM_144803.2110902MouseLentivirus particleZsGreen3xflag (C-Terminal)CMVDetail


CHRNA2 siRNA/miRNA/oligo for RNA interfence (RNAi)

Cat No.Product NameGeneIDSpeciesGradeDetail
pGMoligo1135Pre-made Human CHRNA2 siRNA oligo Duplex1135HumanIn-vitro grade; in-vivo gradeDetail
pGMoligo170945Pre-made Rat Chrna2/ACHR siRNA oligo Duplex170945RatIn-vitro grade; in-vivo gradeDetail
pGMoligo110902Pre-made Mouse Chrna2/Acra2/Acra-2 siRNA oligo Duplex110902MouseIn-vitro grade; in-vivo gradeDetail
pGMoligo712868Pre-made Cynomolgus/Rhesus macaque CHRNA2/nica2 siRNA oligo Duplex712868Cynomolgus/Rhesus macaqueIn-vitro grade; in-vivo gradeDetail
pGMoligo101092104Pre-made Cat/Feline CHRNA2 siRNA oligo Duplex101092104Cat/FelineIn-vitro grade; in-vivo gradeDetail
pGMoligo486101Pre-made Dog/Canine CHRNA2 siRNA oligo Duplex486101Dog/CanineIn-vitro grade; in-vivo gradeDetail
pGMoligo531838Pre-made Bovines/Cattle CHRNA2 siRNA oligo Duplex531838Bovines/CattleIn-vitro grade; in-vivo gradeDetail
pGMoligo100060380Pre-made Equine/Horse CHRNA2 siRNA oligo Duplex100060380Equine/HorseIn-vitro grade; in-vivo gradeDetail


CHRNA2 antibody/GMab

Cat No.SpeciesAntibody NameFormatClassified by tagDetail
GM-Tg-hg-T55815-AbHumanAnti-Human CHRNA2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-rg-T55815-AbRatAnti-Rat CHRNA2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-mg-T55815-AbMouseAnti-Mouse CHRNA2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-cynog-T55815-AbCynomolgus/Rhesus macaqueAnti-Cynomolgus/Rhesus macaque CHRNA2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-felg-T55815-AbCat/FelineAnti-Cat/Feline CHRNA2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-cang-T55815-AbDog/CanineAnti-Dog/Canine CHRNA2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-bovg-T55815-AbBovines/CattleAnti-Bovines/Cattle CHRNA2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-equg-T55815-AbEquine/HorseAnti-Equine/Horse CHRNA2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail


CHRNA2 VLP (virus-like particle)/protein

Cat No.SpeciesAntigen NameExpression PlatformDetail
GM-Tg-hg-T55815-AgHumanHuman CHRNA2 VLP (virus-like particle)HEK293Products Developing
GM-Tg-rg-T55815-AgRatRat CHRNA2 VLP (virus-like particle)HEK293Products Developing
GM-Tg-mg-T55815-AgMouseMouse CHRNA2 VLP (virus-like particle)HEK293Products Developing
GM-Tg-cynog-T55815-AgCynomolgus/Rhesus macaqueCynomolgus/Rhesus macaque CHRNA2 VLP (virus-like particle)HEK293Products Developing
GM-Tg-felg-T55815-AgCat/FelineCat/Feline CHRNA2 VLP (virus-like particle)HEK293Products Developing
GM-Tg-cang-T55815-AgDog/CanineDog/Canine CHRNA2 VLP (virus-like particle)HEK293Products Developing
GM-Tg-bovg-T55815-AgBovines/CattleBovines/Cattle CHRNA2 VLP (virus-like particle)HEK293Products Developing
GM-Tg-equg-T55815-AgEquine/HorseEquine/Horse CHRNA2 VLP (virus-like particle)HEK293Products Developing